Suppr超能文献

通过“原位修饰”策略大规模合成用于癌症治疗的单分散普鲁士蓝纳米颗粒。

Large-scale synthesis of monodisperse Prussian blue nanoparticles for cancer theranostics via an "in situ modification" strategy.

机构信息

Department of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China,

Department of Ultrasound in Medicine, Shanghai Institute of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China,

出版信息

Int J Nanomedicine. 2018 Dec 27;14:271-288. doi: 10.2147/IJN.S183858. eCollection 2019.

Abstract

BACKGROUND

The intrinsic properties of Prussian blue (PB) nanoparticles make them an attractive tool in nanomedicine, including magnetic resonance imaging (MRI), photoacoustic imaging (PAI), and photothermal therapy (PTT) properties. However, there still remains the challenge of their poor dispersible stability in the physiological environment. In this study, we developed an efficient hydrothermal method to address the poor dispersible stability of PB nanoparticles in the physiological environment.

MATERIALS AND METHODS

The concentration of H, the mass of polyvinylpyrrolidone (PVP), and iron sources (K[Fe(CN)]) are very vital in the preparation of PB nanoparticles. Through exploring the preparation process, optimized PB nanoparticles (OPBs) with excellent physiological stability were prepared. Hydrodynamic diameter and UV-vis absorption properties were measured to verify the stability of the prepared OPBs. Properties of dual-mode imaging, including MRI/PAI, and PTT of OPBs were investigated both in vitro and in vivo. In addition, the in vivo biosafety of OPBs was systematically assessed.

RESULTS

OPBs were stable in different environments including various media, pH, and temperatures for at least 90 days, indicating that they are suitable for biomedical application via intravenous administration and easily stored in a robust environment. Compared with other research into the synthesis of PB nanoparticles, the "in situ modification" synthesis of PB nanoparticles had advantages, including a simple process, low cost, and easy mass preparation. OPBs showed no significant signs of toxicity for 90 days. As a proof of concept, the OPBs served as dual-mode image contrast agents and photothermal conversion agents for cancer diagnosis and therapy both in vitro and in vivo.

CONCLUSION

Our findings suggest a facile but efficient strategy with low cost to address the poor dispersible stability of PB nanoparticles in physiological environments. This will promote the development of further clinical transformations of PB nanoparticles, especially in cancer theranostics.

摘要

背景

普鲁士蓝(PB)纳米粒子的固有特性使其成为纳米医学的一种有吸引力的工具,包括磁共振成像(MRI)、光声成像(PAI)和光热治疗(PTT)特性。然而,它们在生理环境中的分散稳定性仍然存在挑战。在这项研究中,我们开发了一种有效的水热法来解决 PB 纳米粒子在生理环境中分散稳定性差的问题。

材料与方法

H 的浓度、聚乙烯吡咯烷酮(PVP)的质量和铁源(K[Fe(CN)])在 PB 纳米粒子的制备中非常重要。通过探索制备过程,制备了具有优异生理稳定性的优化 PB 纳米粒子(OPBs)。测量水动力学直径和紫外-可见吸收特性以验证所制备的 OPBs 的稳定性。研究了 OPBs 的双模成像特性,包括体外和体内的 MRI/PAI 和 PTT。此外,系统评估了 OPBs 的体内生物安全性。

结果

OPBs 在包括各种介质、pH 值和温度在内的不同环境中至少稳定 90 天,表明它们适合通过静脉注射进行生物医学应用,并且可以在坚固的环境中轻松储存。与 PB 纳米粒子合成的其他研究相比,PB 纳米粒子的“原位修饰”合成具有工艺简单、成本低、易于大规模制备等优点。OPBs 在 90 天内没有明显的毒性迹象。作为概念验证,OPBs 作为双重模式的图像对比剂和光热转换剂,用于体外和体内的癌症诊断和治疗。

结论

我们的研究结果表明,一种简单但高效的策略具有低成本,可以解决 PB 纳米粒子在生理环境中的分散稳定性问题。这将促进 PB 纳米粒子在癌症治疗中的进一步临床转化,特别是在癌症治疗方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22d/6312061/88b88719c409/ijn-14-271Fig1.jpg

相似文献

1
Large-scale synthesis of monodisperse Prussian blue nanoparticles for cancer theranostics via an "in situ modification" strategy.
Int J Nanomedicine. 2018 Dec 27;14:271-288. doi: 10.2147/IJN.S183858. eCollection 2019.
2
Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications.
Drug Discov Today. 2020 Aug;25(8):1431-1443. doi: 10.1016/j.drudis.2020.05.014. Epub 2020 May 31.
4
Zn Doped Ultrasmall Prussian Blue Nanotheranostic Agent for Breast Cancer Photothermal Therapy under MR Imaging Guidance.
Adv Healthc Mater. 2020 Jan;9(1):e1900948. doi: 10.1002/adhm.201900948. Epub 2019 Nov 20.
8
Ag-HPBs by a coating-etching strategy and their derived injectable implants for enhanced tumor photothermal treatment.
J Colloid Interface Sci. 2018 Feb 15;512:439-445. doi: 10.1016/j.jcis.2017.10.085. Epub 2017 Oct 25.
10
Prussian Blue Nanoparticles as a Versatile Photothermal Tool.
Molecules. 2018 Jun 11;23(6):1414. doi: 10.3390/molecules23061414.

引用本文的文献

1
Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity.
Nanomedicine (Lond). 2024;19(25):2049-2064. doi: 10.1080/17435889.2024.2389770. Epub 2024 Sep 3.
2
CNN-based glioma detection in MRI: A deep learning approach.
Technol Health Care. 2024;32(6):4965-4982. doi: 10.3233/THC-240158.
4
Bimodal Antimicrobial Surfaces of Phytic Acid-Prussian Blue Nanoparticles-Cationic Polymer Networks.
Adv Sci (Weinh). 2023 Jun;10(16):e2300354. doi: 10.1002/advs.202300354. Epub 2023 Apr 7.
7
8
Photothermal therapy with regulated Nrf2/NF-κB signaling pathway for treating bacteria-induced periodontitis.
Bioact Mater. 2021 Aug 5;9:428-445. doi: 10.1016/j.bioactmat.2021.07.033. eCollection 2022 Mar.
9
The Application of Prussian Blue Nanoparticles in Tumor Diagnosis and Treatment.
Sensors (Basel). 2020 Dec 3;20(23):6905. doi: 10.3390/s20236905.

本文引用的文献

1
Multimodal Prussian blue analogs as contrast agents for X-ray computed tomography.
Dalton Trans. 2018 Aug 29;47(34):11960-11967. doi: 10.1039/c8dt01687a.
2
Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent.
Contrast Media Mol Imaging. 2018 Apr 26;2018:2023604. doi: 10.1155/2018/2023604. eCollection 2018.
3
Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics.
Theranostics. 2017 Jan 6;7(2):466-481. doi: 10.7150/thno.17411. eCollection 2017.
7
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
J Control Release. 2016 Dec 28;244(Pt B):184-193. doi: 10.1016/j.jconrel.2016.06.040. Epub 2016 Jun 28.
8
PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
J Control Release. 2016 Feb 28;224:77-85. doi: 10.1016/j.jconrel.2016.01.009. Epub 2016 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验